Home
Table B29a. Recovery
(percent) of low-molecular-weight PAH analytes added to matrix spike
muscle composites |
|
Composite
#
|
Station
|
Naph-
thalene
|
2-
methyl-
naph-
thalene
|
1-
methyl-
naph-
thalene
|
Biphenyl
|
2,6-
dimethyl-
naph-
thalene
|
Acenaph-
thylene
|
Acenaph-
thene
|
2,3,5-
trimethyl-
naph-
thalene
|
Fluo-
rene
|
Phen-
anthrene
|
Anthra-
cene
|
1-methyl-
phen-
anthrene
|
|
107
|
BL2
|
26
|
38
|
41
|
39
|
46
|
42
|
45
|
49
|
43
|
71
|
58
|
85
|
|
117
|
FL2
|
15
|
22
|
22
|
25
|
28
|
29
|
30
|
38
|
39
|
48
|
60
|
63
|
|
127
|
FL6
|
28
|
32
|
32
|
33
|
36
|
37
|
37
|
41
|
43
|
52
|
59
|
63
|
|
138
|
SB3
|
40
|
46
|
46
|
46
|
47
|
52
|
46
|
46
|
44
|
59
|
65
|
63
|
|
146
|
TA1
|
30
|
36
|
36
|
39
|
42
|
44
|
44
|
47
|
47
|
62
|
68
|
70
|
|
156
|
TA3
|
22
|
27
|
27
|
31
|
33
|
35
|
33
|
40
|
35
|
32
|
40
|
53
|
Table B29b. Recovery
(percent) of high-molecular-weight PAH analytes added to matrix spike
muscle composites |
|
Composite
#
|
Station
|
Fluor-
anthene
|
Pyrene
|
Benz[a]-
anthra-
cene
|
Chry-
sene
|
Benzo[b]-
fluoran-
thene
|
Benzo[k]-
fluoran-
thene
|
Benzo[e]-
pyrene
|
Benzo[a]-
pyrene
|
Pery-
lene
|
Indeno-
[1,2,3-
cd]-
pyrene
|
Dibenz-
[a,h]anth-
racene
|
Benzo-
[ghi]-
perylene
|
|
107
|
BL2
|
88
|
82
|
52
|
50
|
19
|
18
|
17
|
12
|
7
|
30
|
22
|
28
|
|
117
|
FL2
|
69
|
71
|
101
|
90
|
76
|
76
|
62
|
47
|
1
|
32
|
26
|
21
|
|
127
|
FL6
|
64
|
64
|
87
|
77
|
73
|
72
|
67
|
42
|
1
|
55
|
38
|
36
|
|
138
|
SB3
|
69
|
70
|
104
|
88
|
69
|
69
|
57
|
58
|
40
|
34
|
23
|
26
|
|
146
|
TA1
|
73
|
75
|
107
|
94
|
93
|
91
|
79
|
73
|
50
|
82
|
69
|
65
|
|
156
|
TA3
|
60
|
46
|
50
|
43
|
28
|
29
|
23
|
24
|
22
|
14
|
10
|
11
|
From NEFSC Tech Memo NMFS-NE-157 |